
Microsoft's New AI System To Help Decode Protein Motion, Advance Drug Discovery: Satya Nadella
Biomolecular Emulator-1 (BioEmu-1) is a deep learning model that can generate thousands of protein structures per hour on a single graphics processing unit (GPU).
“Understanding protein motion is essential to understanding biology and advancing drug discovery,” said Nadella, in a post on social media platform X.
Sharing a research paper on the model, Nadella added that“today we're introducing BioEmu, an AI system that emulates the structural ensembles proteins adopt, delivering insights in hours that would otherwise require years of simulation”.
Proteins play an essential role -- from forming muscle fibers to protecting against diseases -- in almost all biological processes in both humans and other life forms.
While recent years have seen progress in better understanding of the protein structures, predicting a single protein structure from its amino acid sequence was not feasible.
But, with BioEmu-1, scientists can get a glimpse into the rich world of different structures each protein can adopt, or structural ensembles. This enables them to get a deeper understanding of how proteins work -- critical for designing more effective drugs.
“BioEmu integrates over 200 milliseconds of molecular dynamics (MD) simulations, static structures, and experimental protein stabilities using novel training algorithms. It captures diverse functional motions --including cryptic pocket formation, local unfolding, and domain rearrangements -- and predicts relative free energies with 1 kcal/mol accuracy compared to millisecond-scale MD and experimental data,” revealed scientists from AI for Science at Microsoft Research, in the paper published in the journal Science.
The team noted that BioEmu provides "mechanistic insights by jointly modelling structural ensembles and thermodynamic properties".
The approach pays off the cost of MD and experimental data generation, demonstrating a scalable path toward understanding and designing protein function, they added.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Moonx: The Leading Crypto Trading Platform With X1000 Leverage And Unlimited Meme Coin Access
- T-REX Launches Intelligence Layer To Fix Web3's Value Distribution Problem
- Yield Basis Nears Mainnet Launch As Curve DAO Votes On Crvusd Proposal
- Bydfi Highlights 'BUIDL' Ethos During Newcastle United Match Against Arsenal
- Alt.Town Introduces $TOWN Token Utility Across Platform Services And Launches Valuefi Deposit Event
- Dexari Unveils $1M Cash Prize Trading Competition
Comments
No comment